These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 14656476)

  • 1. Hypogonadotropic hypogonadism as a model of post-natal testicular anti-Müllerian hormone secretion in humans.
    Young J; Rey R; Schaison G; Chanson P
    Mol Cell Endocrinol; 2003 Dec; 211(1-2):51-4. PubMed ID: 14656476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimüllerian hormone in patients with hypogonadotropic hypogonadism.
    Young J; Rey R; Couzinet B; Chanson P; Josso N; Schaison G
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2696-9. PubMed ID: 10443662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testicular anti-mullerian hormone secretion is stimulated by recombinant human FSH in patients with congenital hypogonadotropic hypogonadism.
    Young J; Chanson P; Salenave S; Noël M; Brailly S; O'Flaherty M; Schaison G; Rey R
    J Clin Endocrinol Metab; 2005 Feb; 90(2):724-8. PubMed ID: 15536161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seminal anti-Müllerian hormone level is a marker of spermatogenic response during long-term gonadotropin therapy in male hypogonadotropic hypogonadism.
    Sinisi AA; Esposito D; Maione L; Quinto MC; Visconti D; De Bellis A; Bellastella A; Conzo G; Bellastella G
    Hum Reprod; 2008 May; 23(5):1029-34. PubMed ID: 18343809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary-testicular responsiveness in male hypogonadotropic hypogonadism.
    Weinstein RL; Reitz RE
    J Clin Invest; 1974 Feb; 53(2):408-15. PubMed ID: 11344554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-müllerian hormone and sertoli cell function in paediatric male hypogonadism.
    Grinspon RP; Rey RA
    Horm Res Paediatr; 2010; 73(2):81-92. PubMed ID: 20190544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-müllerian hormone and testosterone serum levels are inversely during normal and precocious pubertal development.
    Rey R; Lordereau-Richard I; Carel JC; Barbet P; Cate RL; Roger M; Chaussain JL; Josso N
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1220-6. PubMed ID: 8077315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testicular growth and spermatogenesis: new goals for pubertal hormone replacement in boys with hypogonadotropic hypogonadism? -a multicentre prospective study of hCG/rFSH treatment outcomes during adolescence.
    Rohayem J; Hauffa BP; Zacharin M; Kliesch S; Zitzmann M;
    Clin Endocrinol (Oxf); 2017 Jan; 86(1):75-87. PubMed ID: 27467188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the tubular and interstitial functions of the testis in 46,XY patients with ambiguous genitalia.
    Stuchi-Perez EG; Lukas-Croisier C; De Castro M; Baptista MT; Ribeiro Scolfaro M; Marques-De-Faria AP; Hackel C; Maciel-Guerra AT; Guerra Júnior G
    J Pediatr Endocrinol Metab; 2000 Jun; 13(6):605-12. PubMed ID: 10905384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions.
    Young J; Couzinet B; Chanson P; Brailly S; Loumaye E; Schaison G
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3239-44. PubMed ID: 10999815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
    Liu L; Banks SM; Barnes KM; Sherins RJ
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like peptide 3 (INSL3) in men with congenital hypogonadotropic hypogonadism/Kallmann syndrome and effects of different modalities of hormonal treatment: a single-center study of 281 patients.
    Trabado S; Maione L; Bry-Gauillard H; Affres H; Salenave S; Sarfati J; Bouvattier C; Delemer B; Chanson P; Le Bouc Y; Brailly-Tabard S; Young J
    J Clin Endocrinol Metab; 2014 Feb; 99(2):E268-75. PubMed ID: 24243640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luteinizing hormone receptor-mediated effects on initiation of spermatogenesis in gonadotropin-deficient (hpg) mice are replicated by testosterone.
    Spaliviero JA; Jimenez M; Allan CM; Handelsman DJ
    Biol Reprod; 2004 Jan; 70(1):32-8. PubMed ID: 12954730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testicular gonadotropin receptors in men with hypogonadotropic hypogonadism.
    Namiki M; Kitamura M; Nonomura N; Nakamura M; Okuyama A; Sonoda T; Matsumoto K
    Arch Androl; 1988; 20(1):81-5. PubMed ID: 3133996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline inhibin B and anti-Mullerian hormone measurements for diagnosis of hypogonadotropic hypogonadism (HH) in boys with delayed puberty.
    Coutant R; Biette-Demeneix E; Bouvattier C; Bouhours-Nouet N; Gatelais F; Dufresne S; Rouleau S; Lahlou N
    J Clin Endocrinol Metab; 2010 Dec; 95(12):5225-32. PubMed ID: 20826577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum inhibin concentrations before and during gonadotropin treatment in men with hypogonadotropic hypogonadism: physiological and clinical implications.
    McLachlan RI; Finkel DM; Bremner WJ; Snyder PJ
    J Clin Endocrinol Metab; 1990 May; 70(5):1414-9. PubMed ID: 2110576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital hypogonadotropic hypogonadism and Kallmann syndrome as models for studying hormonal regulation of human testicular endocrine functions.
    Trabado S; Lamothe S; Maione L; Bouvattier C; Sarfati J; Brailly-Tabard S; Young J
    Ann Endocrinol (Paris); 2014 May; 75(2):79-87. PubMed ID: 24815726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal and cellular regulation of Sertoli cell anti-Müllerian hormone production in the postnatal mouse.
    Al-Attar L; Noël K; Dutertre M; Belville C; Forest MG; Burgoyne PS; Josso N; Rey R
    J Clin Invest; 1997 Sep; 100(6):1335-43. PubMed ID: 9294098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Combined Low Dose Human Gonadotropic Hormone, Follicle Stimulating Hormone, and Testosterone Therapy (LFT Regimen) Versus Conventional High Dose Human Gonadotropic Hormone and Follicle Stimulating Hormone on Spermatogenesis and Biomarkers in Men With Hypogonadotropic Hypogonadism.
    Singhania N; Devi KB; Kaur J; Bhansali A; Gorsi U; Sachdeva N; Arora S; Rai A; Walia R
    Endocr Pract; 2024 Oct; 30(10):978-986. PubMed ID: 39025301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal control of spermatogenesis in men: therapeutic aspects in hypogonadotropic hypogonadism.
    Pitteloud N; Dwyer A
    Ann Endocrinol (Paris); 2014 May; 75(2):98-100. PubMed ID: 24793994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.